Literature DB >> 14245179

NATULAN IN MANAGEMENT OF LATE HODGKIN'S DISEASE, OTHER LYMPHORETICULAR NEOPLASMS, AND MALIGNANT MELANOMA.

I D TODD.   

Abstract

Entities:  

Keywords:  ANTINEOPLASTIC AGENTS; DRUG THERAPY; HODGKIN'S DISEASE; HYDRAZINES; LYMPHOMA, GIANT FOLLICULAR; LYMPHOSARCOMA; MELANOMA; MYCOSIS FUNGOIDES; PALLIATIVE TREATMENT; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1965        PMID： 14245179      PMCID： PMC2166027          DOI： 10.1136/bmj.1.5435.628

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  4 in total

1.  METHYL-HYDRAZINE IN TREATMENT OF HODGKIN'S DISEASE AND VARIOUS FORMS OF HAEMATOSARCOMA AND LEUKAEMIA.

Authors:  G MATHE; O SCHWEISGUTH; M SCHNEIDER; J L AMIEL; L BERUMEN; G BRULE; A CATTAN; L SCHWARZENBERG
Journal:  Lancet       Date:  1963-11-23       Impact factor: 79.321

2.  METHYL-HYDRAZINE IN MALIGNANT DISEASE.

Authors:  K SICHER; T W BACKHOUSE
Journal:  Lancet       Date:  1963-12-14       Impact factor: 79.321

3.  Methylhydrazine derivatives, a new class of cytotoxic agents.

Authors:  P ZELLER; H GUTMANN; B HEGEDUS; A KAISER; A LANGEMANN; M MULLER
Journal:  Experientia       Date:  1963-03-15

4.  Cure of Hodgkin's Disease.

Authors:  E C Easson; M H Russell
Journal:  Br Med J       Date:  1963-06-29
  4 in total
  2 in total

1.  Chemotherapy of Hodgkin's Disease with Cyclophosphamide, Vinblastine, and Procarbazine.

Authors:  G H Fairley; M J Patterson; R B Scott
Journal:  Br Med J       Date:  1966-07-09

2.  Natulan (Procarbazine) combined with radiotherapy in management of inoperable malignant melanoma.

Authors:  G Falkson; P C de Villiers; H C Falkson; T Fichardt
Journal:  Br Med J       Date:  1965-12-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.